Abstract
Background: chronic hepatitis C virus is a major cause of liver-related morbidity and mortality and is known to impair activities of daily living. Direct-acting antivirals have demonstrated high efficacy to achieve sustained virological response in chronic hepatitis C patients. Aim: This study aimed to assess effect of direct acting antiviral treatment on daily living activities for patients with hepatitis C virus. Setting: This study conducted at El-Mataria Daqahlia Health insurance hospital in El-Mataria city, Daqahlia and EL-Tadamon Hospital in Port –Said city. A descriptive sample of 100 male and female adult patients were included in the study. Tools of data collection: Three tools were used to collect study data. First tool is a questionnaire used to assess patient's demographic data, medical and surgical history, the second tool is care dependency scale used to assess level of patient dependency and third tool was daily living scale to assess daily living activities of the study patients. Results: the study results revealed that the majority of sample 73%were dependent as an effect of treatment mostly in activities which need more effort or more cognitive abilities as housekeeping and learning ability while 27% were independent independent mainly in personal activities as continence, getting dressed and undressed. Conclusion. The majority of the sample were nearly independent in personal ADL and physical activities, while about one fourth one- fourth were dependent in other activities which need more effort or more cognitive. Recommendations: Assessment of patient physical, psychological, social and spiritual health behaviors should be a part of routine patient's health assessment. Further study is recommended in a larger sample with considering factors could affecting patient's response to viral hepatitis treatment.
Highlights
Hepatitis C virus is one of Egypt's biggest health problems, Chronic hepatitis is estimated at 71 million people around the world, over 95 percent of people with hepatitis C infection can be fully recovered within 2-3 months, 1.34 million people died from viral hepatitis in 2015, estimated 325 million people have chronic hepatitis infections globally, a large number of people with chronic infection developing cirrhosis or liver cancer (AbdEllatef & Mohamed2019)
Using new treatment program the Ministry of Health initiated the 2014 to 2018 Plan of Action for the Prevention, Care and Treatment of Viral Hepatitis. This program depending on direct-acting antiviral agents which interferes with the hepatitis C virus (HCV) lifecycle and restricts viral replication (Tawfeek et al, 2020)
This study finding goes in the same line with Juanbeltz et al (2018) who conduct a study about impact of successful treatment with direct-acting antiviral agents which found that the mean age of the HCV patients was 52.3 years and nearly two thirds of them were males
Summary
The National Committee for Control of Viral Hepatitis was formed in Egypt in 2006 and developed the new national strategy for control of HCV. The first strategy for control of HCV was applied in 2008 to 2012. It Included 48 weeks treatment with pegylated interferon in combination with ribavirin. Using new treatment program the Ministry of Health initiated the 2014 to 2018 Plan of Action for the Prevention, Care and Treatment of Viral Hepatitis. This program depending on direct-acting antiviral agents which interferes with the HCV lifecycle and restricts viral replication (Tawfeek et al, 2020)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
